Cyproterone Acetate

small molecule

Identifier: CI-DRUG-00000167
Entity page: /drug/cyproterone-acetate ↗
Edges: 22

Neighbours: 5 cancers3 genes1 variants10 trials
Drawn: 19 of 19 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Cyproterone Acetate predicts response to …PREDICTS_RESPONSE_TO1 of 1
← predicts response to	AR Mutationother	resistance	B	Malignant Prostate Neoplasm	1	Curated	civic	graph →
Cyproterone Acetate targets …TARGETS3 of 3
→ targets

Cyproterone Acetate investigated for …INVESTIGATED_FOR2 of 2
→ investigated for	Malignant Prostate Neoplasmcancer	supports	B	Malignant Prostate Neoplasm	1	Curated	civic	graph →
→ investigated for	Prostate Neoplasmsubtype	unknown	3	Prostate Neoplasm	1	Curated	chembl	graph →

Cyproterone Acetate investigated for …INVESTIGATED_FOR2 of 2

→ investigated for

Malignant Prostate Neoplasmcancer

supports

Malignant Prostate Neoplasm

Curated

Cyproterone Acetate investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Malignant Prostate Neoplasmcancer 8 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Prostate Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Endometrial Neoplasm 1 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Endometrial Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Prostate Adenocarcinoma 1 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Prostate Adenocarcinoma	1	Observed	clinicaltrials	graph →

Cyproterone Acetate studied in …STUDIED_INderived10 of 12show all (up to 200)
→ studied in	NCT05316935Phase 2/Phase 3 · recruiting GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients · 12 trials list this drug (1 active)	—	—	Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia,Endometrial Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02460445NA · completed Phlebotomy and Polycystic Ovary Syndrome · 12 trials list this drug (1 active)	—	—	not mapped	1	Observed	clinicaltrials	graph →
→ studied in	NCT04831151NA · unknown The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics · 12 trials list this drug (1 active)	—	—	not mapped	1	Observed	clinicaltrials	graph →
→ studied in	NCT04925180completed A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00003653Phase 3 · completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00196339Phase 2 · completed A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01011751Phase 3 · completed Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma · 12 trials list this drug (1 active)	—	—	Prostate Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00363285Phase 3 · unknown Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00005623Phase 3 · completed Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00919022terminated Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate · 12 trials list this drug (1 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Paths